Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxcarbazepine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 300mg/5 mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 60mg/mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Quantitative measurement of mass concentration of oxcarbazepine in serum or plasma specimen (procedure) |
Component |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
10-hydroxycarbazepine (substance) |
Is a |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine 600 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine 600 mg oral tablet |
Has precise active ingredient |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine 60 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine 60 mg/mL oral suspension |
Has precise active ingredient |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing oxcarbazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only oxcarbazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of mass concentration of oxcarbazepine in serum or plasma specimen (procedure) |
Component |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |